4
Changes in Ownership
CORCEPT THERAPEUTICS INC Filed Acc 0000950170-23-058936
See Remarks sold 25,000 shares at an average $28.10 ($702,601)
- See Remarks acquired 25,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Maduck Sean See Remarks | 2023-11-01 | Option exercise 10b5-1 | +5,112 | $2.61 | $13,342 | 78,403 | D |
| Maduck Sean See Remarks | 2023-11-01 | Sale 10b5-1 | −5,112 | $28.08 | $143,545 | 73,291 | D |
| Maduck Sean See Remarks | 2023-11-02 | Option exercise 10b5-1 | +19,888 | $2.61 | $51,908 | 93,179 | D |
| Maduck Sean See Remarks | 2023-11-02 | Sale 10b5-1 | −19,888 | $28.11 | $559,056 | 73,291 | D |
| Derivatives | |||||||
| Maduck Sean See Remarks | 2023-11-01 | Option exercise · Stock option (right to buy) 10b5-1 | −5,112 | 39,897 | D | ||
| Maduck Sean See Remarks | 2023-11-02 | Option exercise · Stock option (right to buy) 10b5-1 | −19,888 | 20,009 | D | ||
| Open-market sales · 25,000 sh · avg $28.10 · $702,601 | |||||||
Loading xslF345X05/ownership.xml…